FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022302249> ?p ?o ?g. }

• W2022302249 endingPage "1884" @default.
• W2022302249 startingPage "1871" @default.
• W2022302249 abstract "BACKGROUND Thymoma is a rare tumor entity. Surgery remains the mainstay of treatment, but radiation and chemotherapy also have been applied widely in both the adjuvant and the palliative setting. The objective of this study was to review briefly the clinical trials available in the current literature utilizing nonsurgical oncologic treatment (radiotherapy and chemotherapy) either in patients with advanced (i.e., locally inoperable) or metastatic thymoma or as an adjunct to surgery. METHODS A computerized (MEDLINE) and a manual search was performed to identify articles published on this topic between 1965–1998. Only articles with an English abstract were reviewed for inclusion; information abstracted included histologic proof of diagnosis, number of patients, dose and modality of treatment, assessment of response, response rate, survival duration, and side effects. RESULTS Seventy-one trials were identified subsequently. These included 51 chemotherapy studies in a total of 410 patients (including 19 single agent trials and 32 combination chemotherapy trials) and 20 radiotherapy studies. In the adjuvant setting, radiation appeared to result in a higher survival rate compared with historic controls as well as excellent local control in patients with advanced stage of disease, whereas no apparent benefit was observed in patients with Masaoka et al. classified Stage I disease. The large majority of chemotherapeutic studies were case reports or Phase II trials of advanced disease, whereas no prospectively randomized trials were performed. Response rates were relatively heterogeneous and ranged between 24% and 100%, not including the results published in single case reports, and response rates >50% have been found consistently with the application of polychemotherapy. In the absence of randomized trials, multimodality approaches using induction chemotherapy followed by resection and consecutive radiation have produced highly promising results in terms of resectability and long term survival, even in patients with advanced disease. CONCLUSIONS To the authors' knowledge, there is no standard approach to advanced thymoma apart from surgery (i.e., total resection whenever possible). Despite reports of long term disease control, symptomatic palliation, and encouraging survival data, the majority of studies involved only a small number of patients and were performed in a Phase II approach. Large scale, randomized trials to elucidate the potential of multimodality approaches clearly are needed, and patients with thymoma should be included in such studies. Cancer 1999;85:1871–84. © 1999 American Cancer Society." @default.
• W2022302249 created "2016-06-24" @default.
• W2022302249 creator A5031698007 @default.
• W2022302249 creator A5076684030 @default.
• W2022302249 creator A5091065205 @default.
• W2022302249 date "1999-05-01" @default.
• W2022302249 modified "2023-10-11" @default.
• W2022302249 title "Nonsurgical management of malignant thymoma" @default.
• W2022302249 cites W114449418 @default.
• W2022302249 cites W165982544 @default.
• W2022302249 cites W1909030710 @default.
• W2022302249 cites W1966775137 @default.
• W2022302249 cites W1973959930 @default.
• W2022302249 cites W1975225467 @default.
• W2022302249 cites W1977501283 @default.
• W2022302249 cites W1980498794 @default.
• W2022302249 cites W1981999692 @default.
• W2022302249 cites W1984535051 @default.
• W2022302249 cites W1987239762 @default.
• W2022302249 cites W198839891 @default.
• W2022302249 cites W1989767066 @default.
• W2022302249 cites W1990689337 @default.
• W2022302249 cites W1991162476 @default.
• W2022302249 cites W1992021180 @default.
• W2022302249 cites W1992111217 @default.
• W2022302249 cites W1999261331 @default.
• W2022302249 cites W2006322800 @default.
• W2022302249 cites W2007569149 @default.
• W2022302249 cites W2011164480 @default.
• W2022302249 cites W2012147536 @default.
• W2022302249 cites W2012576072 @default.
• W2022302249 cites W2015624964 @default.
• W2022302249 cites W2017923280 @default.
• W2022302249 cites W2019684920 @default.
• W2022302249 cites W2020192330 @default.
• W2022302249 cites W2020808208 @default.
• W2022302249 cites W2021191967 @default.
• W2022302249 cites W2023038782 @default.
• W2022302249 cites W2023265726 @default.
• W2022302249 cites W2024584401 @default.
• W2022302249 cites W2034096683 @default.
• W2022302249 cites W2039572750 @default.
• W2022302249 cites W2043056055 @default.
• W2022302249 cites W2044896416 @default.
• W2022302249 cites W2046113013 @default.
• W2022302249 cites W2048463503 @default.
• W2022302249 cites W2055777261 @default.
• W2022302249 cites W2057295660 @default.
• W2022302249 cites W2063277014 @default.
• W2022302249 cites W2064628166 @default.
• W2022302249 cites W2065810879 @default.
• W2022302249 cites W2069431676 @default.
• W2022302249 cites W2071544699 @default.
• W2022302249 cites W2072497490 @default.
• W2022302249 cites W2072713042 @default.
• W2022302249 cites W2073568991 @default.
• W2022302249 cites W2077682361 @default.
• W2022302249 cites W2083152186 @default.
• W2022302249 cites W2083719902 @default.
• W2022302249 cites W2086023535 @default.
• W2022302249 cites W2086584611 @default.
• W2022302249 cites W2087430856 @default.
• W2022302249 cites W2088178968 @default.
• W2022302249 cites W2089168852 @default.
• W2022302249 cites W2104048219 @default.
• W2022302249 cites W2104738859 @default.
• W2022302249 cites W2105217740 @default.
• W2022302249 cites W2128501533 @default.
• W2022302249 cites W2142910639 @default.
• W2022302249 cites W2148086522 @default.
• W2022302249 cites W2150421767 @default.
• W2022302249 cites W2168468258 @default.
• W2022302249 cites W2268332442 @default.
• W2022302249 cites W2297391501 @default.
• W2022302249 cites W2439437232 @default.
• W2022302249 cites W2467292567 @default.
• W2022302249 cites W2885654561 @default.
• W2022302249 cites W3188803436 @default.
• W2022302249 cites W41061867 @default.
• W2022302249 cites W4240873927 @default.
• W2022302249 cites W4245043686 @default.
• W2022302249 cites W4248073975 @default.
• W2022302249 doi "https://doi.org/10.1002/(sici)1097-0142(19990501)85:9<1871::aid-cncr1>3.0.co;2-y" @default.
• W2022302249 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10223225" @default.
• W2022302249 hasPublicationYear "1999" @default.
• W2022302249 type Work @default.
• W2022302249 sameAs 2022302249 @default.
• W2022302249 citedByCount "48" @default.
• W2022302249 countsByYear W20223022492012 @default.
• W2022302249 countsByYear W20223022492014 @default.
• W2022302249 countsByYear W20223022492015 @default.
• W2022302249 countsByYear W20223022492016 @default.
• W2022302249 countsByYear W20223022492017 @default.
• W2022302249 countsByYear W20223022492018 @default.
• W2022302249 countsByYear W20223022492019 @default.
• W2022302249 countsByYear W20223022492020 @default.
• W2022302249 crossrefType "journal-article" @default.
• W2022302249 hasAuthorship W2022302249A5031698007 @default.

• next